Topic

Moderators

Speakers

Date

Catalyzed exchange of peptide-MHC

Christian Freund

(FU Berlin)

Nikolaos Sgourakis

(University of Pennsylvania)

Jana Sticht

(FU Berlin)

 “Dynamic states are maintained in MHCII allotypes and influence catalyzed
peptide exchange”

Andrew McShan

(Georgia Tech University)

 "Finding Cinderella’s Slipper: How Immunological Chaperones Charm Antigens onto the MHC to Fight Disease”

October 11

5 pm CEST

MHC-bound peptides as candidate T cell epitopes

Miguel Alvaro-Benito

(FU Berlin)

Mathias Wilhelm

(TU München)

"Improving mass spectrometry-based immunopeptidomics by integrating accurate peptide property predictions"

Jenn Abelin

(Broad Institute)

"Integrating immunopeptidome data with proteome and PTM datasets to learn about antigen processing and presentation"

November 1

5 pm CET

MHC as orchestrator of leukemia immunotherapy by allogeneic stem cell transplantation

Katharina Fleischhauer

(University Hospital Essen)

Pietro Crivello

(University Hospital Essen)

“The HLA immunopeptidome as modulator of T-cell alloreactivity in transplantation“

Luca Vago

(San Raffaele Scientific Institute)

 "The Key Role of HLA Alterations in Leukemia Post-Transplantation Relapse“

December 6

5 pm CET

Antigen Specific T cells in disease

Angela Krackhardt

(TU München)

John Maris

(Children´s Hospital Philadelphia)

"Targeting intracellular oncoproteins with peptide-centric cellular therapies"

Dirk Busch

(TU München)

"Advanced engineering of TCR edited T cells for cell therapies"

January 10

5 pm CET

Accessing and manipulating T cell function

Pere Santamaria

(University of Calgary and IDIBAPS)

Sunil Kumar

(DTU Copenhagen)

"Antigen-specific T-cells in SARS-CoV-2infection and vaccination"

Jonathan Schneck

(Johns Hopkins University)

"Engineering Artificial Antigen Presenting Cells, aAPC, for Immunotherapy: From Bench to Bedside"

February 7

5 pm CET

Class I Editors

Peter Cresswell

(Yale University)

Robert Tampé

(Frankfurt University)

David H Margulies

(NIH/NIAID)

"A well-trod surface: MHC-I recognition by ligands and antibodies"

Mariolina Salio

(University of Oxford)

"Tools to understand MR1-dependent antigen presentation"

March 7

5 pm CET

Class II Editors

Lisa Denzin

(Rutgers University)

S. Sadegh-Nasseri

(Johns Hopkins University)

“The ballad of HLA-DO/H2-O: what is new?”

L. Santambrogio

(Weill Cornell Medical College)

"Understanding the Plasticity of the MHC-II Immunopeptidome"

April 4

5 pm CEST

T cell cross-reactivity

Lawrence Stern

(UMass Med School)

Brian Baker

(Univ. of Notre Dame)

Stephanie Gras

(La Trobe University)

"Impact of COVID-19 booster shot vaccine on T cell reactivity & cross-reactivity"

Andy Sewell

(Cardiff University)

“New modes of T-cell recognition from dissection of successful cancer immunotherapy”

May 2

5 pm CEST

Immunogenetics

Tobias Lenz

(Hamburg University)

Alicia Sanchez-Mazas

(Genève University)

"HLA diversity in populations: a textbook case of evolutionary genetics"

Mary Carrington

(Ragon Institute)

"Effect of HLA class I signal peptide variation on HLA-E expression and natural killer cell function"

June 6

5 pm CEST